Delivery Order SPE2DB22D3301-SPE2DB25FX9XV

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,012.19 and is a delivery order for the supply of 4564713961 ELETRIPTAN HBR 40 MG TABLET UD 6S. The contract is not designated as a set-aside and has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,390.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of ELETRIPTAN HBR 40 MG TABLET UD 6S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.69 firm fixed-price delivery order is for the supply of ELETRIPTAN HBR 40 MG TABLET UD 6S, a specialty medication. The contract has an ultimate completion date of September 26, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,638.84, is for the delivery of ELETRIPTAN HBR 40 MG TABLET UD 6S, a medication. The contract has a final completion date of May 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,155.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ELETRIPTAN HBR 20 MG TABLET UD 6S, a pharmaceutical product, and has an ultimate completion date of February 6, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with an identifier of SPE2DB22D3004|SPE2DB25FPF64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELETRIPTAN HBR 40 MG TABLET UD 6S, a pharmaceutical product, with a ceiling value of $2,125.94 and a completion date of January 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,822.32, is for the delivery of Eletriptan HBR 40 mg Tablets and has an ultimate completion date of December 13, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,419.27 firm fixed-price delivery order is for the supply of eletriptan HBR 20 mg tablets. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $1,093.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication eletriptan HBR 20 mg tablets. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product eletriptan hydrobromide 40 mg tablets. The $1,617.17 fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency of the U.S. government. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through 2025. This...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9XV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,669.67, is for the delivery of a specific pharmaceutical product, ELETRIPTAN HBR 40 MG TABLET UD 6S, with a completion date of February 12, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through open competition.

Generated 5/13/25, 10:03 AM